pifithrin has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, X | 1 |
| Muñoz-Alarcón, A | 1 |
| Ajayi, A | 1 |
| Webling, KE | 1 |
| Steinhof, A | 1 |
| Langel, Ü | 1 |
| Ström, AL | 1 |
1 other study available for pifithrin and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model.
Topics: Animals; Ataxin-7; Autophagy; Autophagy-Related Protein-1 Homolog; Benzothiazoles; HEK293 Cells; Hum | 2013 |